Stockscreener 앱 받기
1.80
7.14%
0.12
Adlai Nortye Ltd Adr 주식(ANL)의 최신 뉴스
Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX), Travere Therapeutics (TVTX) and Beyond Air (XAIR) - The Globe and Mail
Analysts Are Bullish on These Healthcare Stocks: Kura Oncology (KURA), Health Catalyst (HCAT) - The Globe and Mail
Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Sees Significant Increase in Short Interest - Defense World
TerraVest Industries (TSE:TVK) Price Target Raised to C$209.00 at Canaccord Genuity Group - Defense World
Scotiabank Issues Positive Forecast for Quebecor (TSE:QBR.B) Stock Price - Defense World
Teledyne Technologies (NYSE:TDY) Given New $579.00 Price Target at Barclays - Defense World
Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Short Interest Up 6,821.4% in December - MarketBeat
Adlai Nortye narrows first-half 2025 loss as oncology pipeline advances - MSN
Why Baidu Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket - Sahm
Adlai Nortye Ltd. Shareholders Approve Redomiciliation to Singapore - MSN
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Xoma (XOMA) and Adlai Nortye Ltd. Sponsored ADR (ANL) - The Globe and Mail
Why Fonar Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket - Sahm
Adlai Nortye Ltd ADR (ANL-Q) Stock Price and News - The Globe and Mail
Adlai Nortye licenses cancer drug to ASK Pharm in $230 million deal By Investing.com - Investing.com South Africa
Adlai Nortye shares soar on $230 million licensing deal with ASK Pharm By Investing.com - Investing.com South Africa
Adlai Nortye shares soar on $230 million licensing deal with ASK Pharm - Investing.com India
Adlai Nortye Licenses Pan-RAS Inhibitor AN9025 to ASK Pharm for Greater China - TipRanks
Adlai Nortye licenses cancer drug to ASK Pharm in $230 million deal - Investing.com
Adlai Nortye Enters Exclusive License Agreement with ASK Pharm for Pan-RAS (ON) Inhibitor AN9025 in Greater China - Sahm
Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Short Interest Update - MarketBeat
Adlai Nortye (NASDAQ:ANL) Trading 1% HigherWhat's Next? - MarketBeat
Adlai Nortye (NASDAQ:ANL) Trading 1% Higher – What’s Next? - Defense World
Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK) and Regeneron (REGN) - The Globe and Mail
Adlai Nortye Ltd. Sponsored ADR Cash Flow – LS:A3EEED - TradingView — Track All Markets
Total common shares outstanding of Adlai Nortye Ltd. Sponsored ADR – LS:A3EEED - TradingView — Track All Markets
Analysts Offer Insights on Healthcare Companies: Rigel (RIGL), Terns Pharmaceuticals (TERN) and Pyxis Oncology (PYXS) - The Globe and Mail
Analysts Are Bullish on Top Healthcare Stocks: Adicet Bio (ACET), Palvella Therapeutics (PVLA) - The Globe and Mail
Adlai Nortye (NASDAQ:ANL) Shares Down 1.4% – Here’s Why - Defense World
Adlai Nortye (NASDAQ:ANL) Shares Down 1.4%Here's Why - MarketBeat
Adlai Nortye to Participate in Upcoming Investor Conferences - GlobeNewswire Inc.
Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Vera Therapeutics (VERA) and Varex Imaging (VREX) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Schrodinger (SDGR), Lexicon Pharmaceuticals (LXRX) and Cullinan Management (CGEM) - The Globe and Mail
H.C. Wainwright Reaffirms Their Hold Rating on Adlai Nortye Ltd. Sponsored ADR (ANL) - The Globe and Mail
Adlai Nortye Ltd. Plans Redomiciliation to Singapore - MSN
Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Short Interest Up 92.3% in September - MarketBeat
HC Wainwright Comments on Adlai Nortye FY2025 Earnings - MarketBeat
Adlai Nortye (NASDAQ:ANL) Trading Down 3.1%Here's Why - MarketBeat
GASFRAC Energy Services (OTCMKTS:GSFVF) Shares Cross Above 200 Day Moving Average – What’s Next? - Defense World
Chart based analysis of Adlai Nortye Ltd. Depositary Receipt trendsQuarterly Risk Review & Low Volatility Stock Recommendations - newser.com
Can technical indicators confirm LZ Technology Holdings Limited’s reversalMarket Weekly Review & AI Powered Market Entry Ideas - newser.com
How to monitor COHU with trend dashboards2025 Geopolitical Influence & Verified Momentum Stock Watchlist - newser.com
Can machine learning forecast Ubiquiti Inc. recoveryQuarterly Portfolio Summary & Community Verified Watchlist Alerts - newser.com
Top chart patterns to watch in ECARX Holdings Inc. Equity WarrantWeekly Trade Summary & Technical Pattern Based Signals - newser.com
Analysts Offer Insights on Healthcare Companies: Intensity Therapeutics, Inc. (INTS), AnaptysBio (ANAB) and Adlai Nortye Ltd. Sponsored ADR (ANL) - The Globe and Mail
Visual analytics tools that track Adlai Nortye Ltd. Depositary Receipt performanceMarket Sentiment Summary & Fast Moving Stock Trade Plans - newser.com
Does PBHC show high probability of reboundJuly 2025 Recap & AI Powered Buy and Sell Recommendations - newser.com
Risk vs reward if holding onto Penns Woods Bancorp Inc.2025 Key Highlights & Smart Money Movement Alerts - newser.com
Is MSBI trending in predictive chart modelsQuarterly Profit Review & High Accuracy Buy Signal Tips - newser.com
Short Interest in Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Declines By 65.7% - MarketBeat
Does Bentley Systems Incorporated qualify in momentum factor screening2025 Key Highlights & Consistent Return Investment Signals - newser.com
Earnings visualization tools for WSO.BJuly 2025 Market Mood & Safe Entry Trade Reports - newser.com
Earnings visualization tools for DBRG.PRJQuarterly Trade Review & Daily Growth Stock Investment Tips - newser.com
Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Sees Large Decrease in Short Interest - Defense World
Analysts Set Teradata Corporation (NYSE:TDC) PT at $26.86 - Defense World
4.73%
0.92%
자본화:
|
볼륨(24시간):